4th Quarter - Report
FORBES-TATE for PHRMA
Firm
Client
Income
$80,000
Expenses
—
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Issues pertaining to Rx Drug pricing; Issues related to IPAB; Medicare Part D; Importation of drugs; Issues related to 340b; Issues related to Hatch-Waxman, Drug Price Competition and Patent Term Restoration Act (Public Law 98-417).
| Lobbyist | Covered position, as disclosed |
|---|---|
| CYNTHIA BROWN New | Leg Assistant, Rep. Stupak, 1993-1994 Leg Director, Rep. Kind, 1999-2002 Chief of Staff, Rep. Kind, 2003-2009 |
| JEFFREY FORBES | — |
| ELIZABETH GREER | — |
| JEFFREY SADOSKY | — |
| DERRICK M WHITE | — |
Pharmacy PHA
Issues pertaining to Rx Drug pricing.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CYNTHIA BROWN New | Leg Assistant, Rep. Stupak, 1993-1994 Leg Director, Rep. Kind, 1999-2002 Chief of Staff, Rep. Kind, 2003-2009 |
| JEFFREY FORBES | — |
| ELIZABETH GREER | — |
| JEFFREY SADOSKY | — |
| DERRICK M WHITE | — |
Medicare/Medicaid MMM
Issues pertaining to Rx Drug pricing.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CYNTHIA BROWN New | Leg Assistant, Rep. Stupak, 1993-1994 Leg Director, Rep. Kind, 1999-2002 Chief of Staff, Rep. Kind, 2003-2009 |
| JEFFREY FORBES | — |
| ELIZABETH GREER | — |
| JEFFREY SADOSKY | — |
| DERRICK M WHITE | — |
Consumer Issues/Safety/Products CSP
Issues related to Direct to Consumer (DTC) Advertising.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CYNTHIA BROWN New | Leg Assistant, Rep. Stupak, 1993-1994 Leg Director, Rep. Kind, 1999-2002 Chief of Staff, Rep. Kind, 2003-2009 |
| JEFFREY FORBES | — |
| ELIZABETH GREER | — |
| JEFFREY SADOSKY | — |
| DERRICK M WHITE | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.